Mechanisms inactivating the gene for E-cadherin in sporadic gastric carcinomas

Yao-Chi Liu1, Chen-Yang Shen, Hurng-Sheng Wu

  • 1Division of General Surgery, Tri-Service General Hospital, No. 325, Sec 2, Cheng-Kung Road, Taipei, Taiwan, China. dlyaochi@yahoo.com.tw

Abstract

Insights

CDH1 gene inactivation in gastric cancer involves loss of heterozygosity (LOH) and promoter hypermethylation, but not typically mutations or polymorphisms. These two major mechanisms appear to be independent pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • CDH1/E-cadherin (E-cad) is a crucial tumor suppressor gene.
  • Alterations in CDH1 are implicated in gastric carcinoma (GC) pathogenesis.
  • Understanding E-cad inactivation mechanisms is vital for GC research.

Purpose of the Study:

  • To investigate CDH1 gene alteration profiles in gastric carcinoma.
  • To determine the roles of mutation, LOH, promoter polymorphism, and hypermethylation in CDH1 inactivation.
  • To elucidate the pathways leading to E-cad loss in GC.

Main Methods:

  • Analysis of 70 surgically collected GC specimens.
  • Utilized techniques including PCR, LOH detection, DNA sequencing, RFLP, methylation-specific PCR, and immunohistochemistry.
  • Examined mutation, LOH, promoter polymorphism, and hypermethylation of CDH1.

Main Results:

  • Promoter polymorphism and somatic mutations were infrequent mechanisms of E-cad inactivation in GC.
  • Loss of heterozygosity (LOH) and CDH1 promoter hypermethylation were identified as major inactivation mechanisms.
  • An inverse relationship was observed between LOH and hypermethylation, suggesting distinct tumorigenic pathways.

Conclusions:

  • The classical two-hit hypothesis for CDH1 inactivation is not met by common combinations of mutation, LOH, and hypermethylation.
  • E-cadherin inactivation in GC likely involves additional mechanisms.
  • Further research into transcriptional or post-translational regulation of E-cadherin is warranted.

Related Concept Videos

Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Structure of Cadherins01:25

Structure of Cadherins

The cadherins were one of the first cell adhesion molecules discovered; the term “cadherins”   is based on their calcium-dependent adhering properties. The first cadherins discovered on the epithelial, neuronal, and placental cells were named E-cadherin, P-cadherin, and N-cadherin, respectively. These classical cadherins share sequence and structural similarities. Other cadherins, including those involved in cell signaling, are grouped into non-classical cadherins. This diversity of cadherins...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.